CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier","$":{"href":"/biotech/novartis-pays-sironax-125m-acquire-platform-crossing-blood-brain-barrier","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Novartis has acquired Sironax's blood-brain barrier crossing platform for $125 million, gaining control of technology to deliver large molecules to central nervous system targets.

Importance:7/10
Sentiment:
0.60
acquisitionblood-brain barrierCNSplatform technologydrug delivery
Related Companies

Read the original article

Published by FierceBiotech on September 16, 2026 8:32 AM

Read Original